For many Americans struggling to lose weight, powerful new medications are changing the game. With roughly 40% of U.S. adults living with obesity, according to the Centers for Disease Control ...

Tirzepatide, an injection medication already approved by the Food and Drug Administration (FDA) to treat Type 2 diabetes, is likely to receive FDA approval for another indication — weight loss — later ...

The FDA has spent much of 2025 issuing warnings about a single, recurring problem with GLP-1 weight loss drugs: patients and ...

Eli Lilly said copycat versions of Zepbound that add B12 result in potentially dangerous impurities. The compounding industry ...

The US Food and Drug Administration (FDA) has approved tirzepatide for chronic weight management in adults with obesity or overweight. "Obesity and overweight are serious conditions that can be ...

Mounjaro (tirzepatide) is prescribed to manage blood sugar levels in people with type 2 diabetes. It’s available as a single-dose prefilled pen. You will administer your Mounjaro injections into your ...

Weight loss injections have gained popularity as a quick solution for shedding pounds, but are they safe? We’ll explore the safety, benefits and potential risks associated with weight loss injections ...

India's drug regulator tightened surveillance against unauthorized sale and promotion of weight-loss drugs, the country's ...

Stopping popular weight-loss injections like Ozempic or Mounjaro might not trigger the dramatic rebound many fear. A large real-world study of nearly 8,000 patients found that most people who ...